Estimation of the Burden of Rotavirus Gastroenteritis (RV GE) in Children Less Than 5 Years in Greece

February 14, 2013 updated by: GlaxoSmithKline

To Estimate the Burden of Rotavirus Gastroenteritis (RV GE) in Children < 5 Years of Age in Greece

The purpose of this study is to measure the disease burden from RV GE among children less than 5 years of age using hospital surveillance data. In addition, data collected will determine the seasonal distribution, disease severity, age distribution of RV GE. From an economic standpoint, the cost and impact of RV will also be assessed.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

128

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Athens, Greece, 11527
        • GSK Investigational Site
      • Athens, Greece, 104 46
        • GSK Investigational Site
      • Heraklion, Crete, Greece, 71409
        • GSK Investigational Site
      • Rio/Patras, Greece, 26500
        • GSK Investigational Site
      • Thessaloniki, Greece, 54636
        • GSK Investigational Site
      • Thessaloniki, Greece, 546 38
        • GSK Investigational Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 5 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Children < 5 years of age seen at the selected hospital sites for acute GE (e.g. subjects treated at the hospital or visiting the emergency room for an acute GE episode or developed acute GE at least 48 hours after hospitalisation) with a rapid screen positive test result to RV.

Description

Inclusion Criteria:

  • A male or female child < 5 years of age at the time of the visit (a child becomes ineligible on the day of her/his 5th birthday).
  • Child is brought to the emergency room for acute GE during the study period or develop acute GE at least 48 hours after hospitalisation.
  • Written informed consent obtained from the parent/guardian of the subject.
  • Children with RV positive stool sample will be enrolled in the study.

Exclusion Criteria:

• Not applicable.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
RV GE Group
Collection of the stool at least 48 hours after hospitalisation. Stool samples should be obtained preferably within 4 and no later than 10 days after the onset of the GE symptoms.
Logbook, Health Economic Questionnaire, Telephone call.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Estimation of the proportion of RV GE among all acute GE emergency room visits among children <5 years of age.
Time Frame: Approximately 12 months
Approximately 12 months
Estimation of the proportion of RV GE among all acute GE hospitalisations among children <5 years of age.
Time Frame: Approximately 12 months
Approximately 12 months
Estimation of the incidence of nosocomial RV GE among all hospitalised children <5 years of age.
Time Frame: Approximately 12 months
Approximately 12 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Determination of the age of the children, disease severity, and the seasonal distribution of RV GE among children <5 years of age.
Time Frame: Approximately 12 months
Approximately 12 months
Assessing the costs related to the episodes of RV GE, by the completion of the Health Economic Questionnaire (interview with the parent for a subset of subjects) and the cost checklist provided by the hospital's site staff.
Time Frame: Approximately 12 months
Approximately 12 months
Identification of prevalent genotypes of RV among children <5 years of age.
Time Frame: Approximately 12 months
Approximately 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2008

Primary Completion (Actual)

March 1, 2010

Study Completion (Actual)

March 1, 2010

Study Registration Dates

First Submitted

September 11, 2008

First Submitted That Met QC Criteria

September 11, 2008

First Posted (Estimate)

September 12, 2008

Study Record Updates

Last Update Posted (Estimate)

February 18, 2013

Last Update Submitted That Met QC Criteria

February 14, 2013

Last Verified

February 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • 109355

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rotavirus Gastroenteritis

Clinical Trials on Stool sample

3
Subscribe